Technical Analysis for CYT - Cyteir Therapeutics, Inc.

Grade Last Price % Change Price Change
F 17.37 -0.34% -0.06
CYT closed down 0.34 percent on Monday, October 25, 2021, on 32 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical CYT trend table...

Date Alert Name Type % Chg
Hammer Candlestick Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
50 DMA Resistance Bearish -0.34%
Fell Below 20 DMA Bearish -0.34%
Fell Below 50 DMA Bearish -4.30%
Crossed Above 50 DMA Bullish -6.91%
Pocket Pivot Bullish Swing Setup -6.91%
Doji - Bearish? Reversal -6.91%
Older End-of-Day Signals for CYT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 13 hours ago
60 Minute Opening Range Breakdown about 15 hours ago
Fell Below Previous Day's Low about 17 hours ago
Down 2 % about 17 hours ago
Down 1% about 18 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Cyteir is a clinical-stage oncology company that is focused on the discovery and development of next-generation synthetically lethal therapies to treat cancer. The company is using its expertise in DNA damage response biology to advance a pipeline of novel drug candidates that selectively target key cancer vulnerabilities. Cyteir’s wholly owned lead compound, CYT-0851, is a potent and selective, oral investigational drug that was designed to inhibit RAD51-mediated homologous recombination and the repair of double-strand DNA breaks.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Biology Molecular Genetics Recombination

Is CYT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 23.1
52 Week Low 14.01
Average Volume 131,000
200-Day Moving Average 0.00
50-Day Moving Average 18.37
20-Day Moving Average 17.81
10-Day Moving Average 17.59
Average True Range 1.40
ADX 10.16
+DI 19.60
-DI 18.34
Chandelier Exit (Long, 3 ATRs) 15.63
Chandelier Exit (Short, 3 ATRs) 19.49
Upper Bollinger Bands 19.49
Lower Bollinger Band 16.14
Percent B (%b) 0.37
BandWidth 18.80
MACD Line -0.16
MACD Signal Line -0.24
MACD Histogram 0.0742
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.20
Resistance 3 (R3) 18.14 17.81 18.06
Resistance 2 (R2) 17.81 17.60 17.84 18.01
Resistance 1 (R1) 17.59 17.47 17.43 17.65 17.97
Pivot Point 17.26 17.26 17.18 17.29 17.26
Support 1 (S1) 17.04 17.05 16.88 17.10 16.77
Support 2 (S2) 16.71 16.92 16.74 16.73
Support 3 (S3) 16.49 16.71 16.68
Support 4 (S4) 16.55